Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 4Phase 1 4Phase 4 3Phase 3 3Phase 2/3 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Erectile Dysfunction 2Rectal Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Sildenafil Citrate × Clear all
NCT06123156 2026-05-12

RECTIL

University Hospital, Rouen

Phase 3 Recruiting
188 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00544076 2019-01-02

ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer

City of Hope Medical Center

Phase 3 Terminated
110 enrolled 9 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00142506 2017-10-20

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
290 enrolled 7 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡